Urologic Oncology: Seminars and Original Investigations
Volume 25, Issue 2 , Pages 110-114 , March 2007

Pathologic findings at radical prostatectomy: Risk factors for failure and death

  • Gregory P. Swanson, M.D.

      Affiliations

    • University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-210-616-5648; fax: +1-210-949-5085.
    • ,
  • Mark Riggs, Ph.D.

      Affiliations

    • Abilene Christian University, Abilene, TX 79699, USA
    • ,
  • Michael Hermans, M.D.

      Affiliations

    • Scott and White Clinic, Temple, TX 76508, USA

Received 29 December 2005 ,Revised 7 June 2006 ,Accepted 7 June 2006.

References 

  1. Zincke H, Bergstralh EJ, Blute ML, et al. Radical prostatectomy for clinically localized prostate cancer: Long-term results of 1,143 patients from a single institution. J Clin Oncol. 1994;12:2254–2263
  2. Han M, Partin AW, Zahurak M, et al. Biochemical (Prostate Specific Antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003;169:517–523
  3. Swanson GP, Riggs MW, Earle JD, et al. Long-term follow-up of radical prostatectomy for prostate cancer. Eur Urol. 2002;42:212–216
  4. American Joint Committee on CancerAmerican Cancer SocietyAmerican College of Surgeons. AJCC cancer staging manual. 5th ed.. Philadelphia (PA): Lippincott-Raven; 1997;
  5. Roehl KA, Han M, Ramos CG, et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results. J Urol. 2004;172:910–914
  6. Kupelian PA, Katcher J, Levin HS, et al. Stage T1-2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int J Radiat Oncol Biol Phys. 1997;37:1043–1052
  7. Han M, Partin AW, Pound CR, et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy (The 15-year Johns Hopkins experience). Urol Clin North Am. 2001;28:555–565
  8. Babaian RJ, Troncoso P, Bhadkamkar VA, et al. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer. 2001;91:1414–1422
  9. Freedland SJ, Aronson WJ, Terris MK, et al. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: Results from SEARCH database. J Urol. 2003;169:2136–2141

PII: S1078-1439(06)00150-5

doi: 10.1016/j.urolonc.2006.06.003

Urologic Oncology: Seminars and Original Investigations
Volume 25, Issue 2 , Pages 110-114 , March 2007

Article Tools

* Image Usage & Resolution